Close

 

Fund Holdings (%)1,2 as of Feb 29, 2024

Holding % of Net Assets
Eli Lilly & Co 9.40%
UnitedHealth Group Inc 6.88%
Novo Nordisk A/S 6.56%
AbbVie Inc 5.41%
Thermo Fisher Scientific Inc 5.11%
AstraZeneca PLC 4.31%
Danaher Corp 3.96%
Intuitive Surgical Inc 3.83%
Roche Holding AG 3.61%
Johnson & Johnson 3.54%
Boston Scientific Corp 3.48%
Zoetis Inc 3.34%
Stryker Corp 3.33%
Sanofi 3.20%
Vertex Pharmaceuticals Inc 2.61%
Merck & Co Inc 2.52%
Bristol-Myers Squibb Co 2.28%
Alcon Inc 2.11%
CSL Ltd 2.08%
McKesson Corp 2.04%
Cooper Cos Inc 1.86%
SPDR S&P Biotech ETF 1.86%
Neurocrine Biosciences Inc 1.71%
Centene Corp 1.25%
Lonza Group AG 1.15%
IDEXX Laboratories Inc 1.13%
Royalty Pharma PLC 0.94%
Pfizer Inc 0.93%
Humana Inc 0.92%
Zimmer Biomet Holdings Inc 0.84%
Align Technology Inc 0.84%
ARGENX SE - ADR 0.81%
Sartorius AG 0.80%
Amplifon SpA 0.80%
Teleflex Inc 0.79%
MSILF GOVERNMENT PORTFOLIO 0.78%
Straumann Holding AG 0.75%
Neogen Corp 0.70%
AptarGroup Inc 0.61%
Asahi Intecc Co Ltd 0.52%
JMDC Inc 0.20%
CARIS LIFE SCIENCES, INC 0.05%